Three‐Year Outcomes from BENEFIT, a Randomized, Active‐Controlled, Parallel‐Group Study in Adult Kidney Transplant Recipients von Vincenti, F., Larsen, C. P., Alberu, J., Bresnahan, B., Garcia, V. D., Kothari, J., Lang, P., Urrea, E. Mancilla, Massari, P., Mondragon‐Ramirez, G., Reyes‐Acevedo, R., Rice, K., Rostaing, L., Steinberg, S., Xing, J., Agarwal, M., Harler, M. B., Charpentier, B.

Volltext

Reduced Risk of Cytomegalovirus Infection in Solid Organ Transplant Recipients Treated With Sirolimus: A Pooled Analysis of Clinical Trials von Demopoulos, L, Polinsky, M, Steele, G, Mines, D, Blum, M, Caulfield, M, Adamkovic, A, Liu, Q, Harler, M.B, Hahn, C, Singh, A

Volltext

Three‐Year Outcomes From BENEFIT‐EXT: A Phase III Study of Belatacept Versus Cyclosporine in Recipients of Extended Criteria Donor Kidneys von Medina Pestana, J. O., Grinyo, J. M., Vanrenterghem, Y., Becker, T., Campistol, J. M., Florman, S., Garcia, V. D., Kamar, N., Lang, P., Manfro, R. C., Massari, P., Rial, M. D. C., Schnitzler, M. A., Vitko, S., Duan, T., Block, A., Harler, M. B., Durrbach, A.

Volltext

Belatacept‐Based Immunosuppression in De Novo Liver Transplant Recipients: 1‐Year Experience From a Phase II Randomized Study von Klintmalm, G. B., Feng, S., Lake, J. R., Vargas, H. E., Wekerle, T., Agnes, S., Brown, K. A., Nashan, B., Rostaing, L., Meadows‐Shropshire, S., Agarwal, M., Harler, M. B., García‐Valdecasas, J.‐C.

Volltext

Prevalence and time course of arrhythmia-induced cardiomyopathy in patients with newly diagnosed heart failure and concomitant tachyarrhythmia – the TACHY-HF pilot trial von Schach, C, Koertl, T, Harler, B, Muehlbeck, F, Baum, P, Meindl, C, Lavall, D, Zeman, F, Koller, M, Resch, M, Baessler, A, Maier, L.S, Wachter, R, Sossalla, S.T

Volltext

Increased neutrophil motility by β-glucan in the absence of chemoattractant von HARLER, Mary Beth, REICHNER, Jonathan

Volltext

Long-Term Extension of the Belatacept BENEFIT Study: Results at Month 48: 746 von Vincenti, F., Charpentier, B., Rostaing, L., Reyes-Acevedo, R., Massari, P., Vitko, S., Alberu, J., Harler, M. B., Duan, T., Larsen, C.

Volltext

Long-Term Extension of the Belatacept BENEFIT Study: Results at Month 48: 746 von Vincenti, F., Charpentier, B., Rostaing, L., Reyes-Acevedo, R., Massari, P., Vitko, S., Alberu, J., Harler, M. B., Duan, T., Larsen, C.

Volltext

Long-Term Extension of the Belatacept BENEFIT-EXT Study: Results at Month 48: 760 von Grinyo, J., Florman, S., Medina Pestana, J. O., del Carmen Rial, M., Muehlbacher, F., Durrbach, A., Vincenti, F., Harler, M. B., Duan, T., Rostaing, L.

Volltext

Belatacept-Based Immunosuppression in De Novo Liver Transplant Recipients: 1-Year Experience From a Phase II Randomized Study von KLINTMALM, G. B, FENG, S, AGARWAL, M, HARLER, M. B, GARCIA-VALDECASAS, J.-C, LAKE, J. R, VARGAS, H. E, WEKERLE, T, AGNES, S, BROWN, K. A, NASHAN, B, ROSTAING, L, MEADOWS-SHROPSHIRE, S

Volltext

Isolated Iliac Artery Dissection Secondary to Fibromuscular Dysplasia: Three Cases in Young Adults von Harler, Mary Beth, Weyman, Albert, Capt, Raymond Bozman, Sullivan, Deborah, Patterson, Robert

Volltext

Promotion of Neutrophil Chemotaxis Through Differential Regulation of beta sub(1) and beta sub(2) Integrins von Harler, M B, Wakshull, E, Filardo, E J, Albina, JE, Reichner, J S

Volltext

Promotion of neutrophil chemotaxis through differential regulation of beta 1 and beta 2 integrins von Harler, M B, Wakshull, E, Filardo, E J, Albina, J E, Reichner, J S

Volltext

Highly stoichiometric, stable, and specific association of integrin alpha3beta1 with CD151 provides a major link to phosphatidylinositol 4-kinase, and may regulate cell migration von Yauch, R L, Berditchevski, F, Harler, M B, Reichner, J, Hemler, M E

Volltext

Thallium lung-to-heart quantification: three methods of evaluation von HARLER, M. B, MAHONEY, M, BARTLETT, B, PATEL, K, TURBINER, E

Volltext

Renal Function at 4 Years in a Phase 2 Randomized Trial Evaluating Belatacept-Based Regimens With Simultaneous Calcineurin Inhibitor and Corticosteroid Avoidance in Kidney Transpla... von Woodle, E., Marder, B., Harler, M., Vincenti, F., Citterio, F., Nori, U., Grinyo, J.

Volltext

Outcomes at 4 Years in a Randomized Trial Evaluating Belatacept-Based Regimens With Simultaneous CNI and Steroid-Avoidance in Kidney Transplant: Abstract# 2162 von Grinyo, J., Marder, B., Harler, M., Vincenti, F., Citterio, F., Nori, U., Woodle, E.

Volltext

Evaluation of Donor-Specific Antibodies Through 5 Years With Belatacept in BENEFIT and BENEFIT-EXT: Abstract# 2163 von Bray, R., Gebel, H., Brannon, P., Ganguly, B., Townsend, R., Meier-Kriesche, U., Harler, M., Larsen, C.

Volltext

Canephron N reduced immune cell recruitment in experimental cystitis von Nausch, B, Röhrl, J, Koeberle, A, Harler, U, Joannidis, M, Werz, O, Künstle, G

Volltext

138 - Canephron N reduced immune cell recruitment in experimental cystitis von Nausch, B., Röhrl, J., Koeberle, A., Harler, U., Joannidis, M., Werz, O., Künstle, G.

Volltext